1,337
Views
13
CrossRef citations to date
0
Altmetric
Articles

The effect of nanofibre-based polyethersulfone (PES) scaffold on the chondrogenesis of human induced pluripotent stem cells

, , , , , , , , & show all
Pages 1948-1956 | Received 13 Jul 2017, Accepted 22 Oct 2017, Published online: 06 Nov 2017

Figures & data

Table 1. Primers used for real-time PCR.

Figure 1. EB formation. Formation of EBs with serial dripping. Each drop of culture medium contained ∼2 − 5×10 cells, which congregated and developed into an EB.

Figure 1. EB formation. Formation of EBs with serial dripping. Each drop of culture medium contained ∼2 − 5×10 cells, which congregated and developed into an EB.

Figure 2. SEM imaging. Morphology of fabricated PES scaffold (A) Morphology of IPSC without differentiation (B and C) chondrogenic differentiated IPSC on nanofibrous PES (D and E).

Figure 2. SEM imaging. Morphology of fabricated PES scaffold (A) Morphology of IPSC without differentiation (B and C) chondrogenic differentiated IPSC on nanofibrous PES (D and E).

Figure 3. Proliferation of IPSC on TCPS and scaffold during a 24, 48, 76 and 96 h culture period, Results are presented as mean ± SD. Significant levels are *p < .05 and **p < .001.

Figure 3. Proliferation of IPSC on TCPS and scaffold during a 24, 48, 76 and 96 h culture period, Results are presented as mean ± SD. Significant levels are *p < .05 and **p < .001.

Figure 4. In vitro expression analysis of collagen type II and aggrecan markers on PES Scaffold. Immunofluorescence for collagen type II (A) and aggrecan markers (B) in chondrogenic differentiated IPSC after 21 d of in vitro differentiation. Staining of nucleus was performed by DAPI (blue), scale bars are 100 μm.

Figure 4. In vitro expression analysis of collagen type II and aggrecan markers on PES Scaffold. Immunofluorescence for collagen type II (A) and aggrecan markers (B) in chondrogenic differentiated IPSC after 21 d of in vitro differentiation. Staining of nucleus was performed by DAPI (blue), scale bars are 100 μm.

Figure 5. In vitro expression analysis of collagen II and aggrecan markers on the scaffold free method after 21 d. Type II collagen (A), and aggreacan (B), scale bars are 100 μm. Staining of nucleus was performed by DAPI (blue), scale bars are 100 μm.

Figure 5. In vitro expression analysis of collagen II and aggrecan markers on the scaffold free method after 21 d. Type II collagen (A), and aggreacan (B), scale bars are 100 μm. Staining of nucleus was performed by DAPI (blue), scale bars are 100 μm.

Figure 6. Expression of cartilage-specific genes. Relative expression of aggrecan, collagen I, collagen II, collagen X and SOX9 in IPSC cultured on PES scaffold during chondrogenic differentiation compared to scaffold free method. The expressions of collagen II, collagen X and aggrecan genes were significantly upregulated in PES scaffold compared to that in scaffold free method. Collagen type I expression was down regulated at the end of cultivation and also, SOX9 gene expression did not show a significant difference during chondrogenic differentiation of IPSC on both scaffolds. Results are presented as mean ± SD. Significant levels are **p < .01, ***p < .001 and ****p < .0001.

Figure 6. Expression of cartilage-specific genes. Relative expression of aggrecan, collagen I, collagen II, collagen X and SOX9 in IPSC cultured on PES scaffold during chondrogenic differentiation compared to scaffold free method. The expressions of collagen II, collagen X and aggrecan genes were significantly upregulated in PES scaffold compared to that in scaffold free method. Collagen type I expression was down regulated at the end of cultivation and also, SOX9 gene expression did not show a significant difference during chondrogenic differentiation of IPSC on both scaffolds. Results are presented as mean ± SD. Significant levels are **p < .01, ***p < .001 and ****p < .0001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.